“…In previous studies, many screened or genetically engineered yeast strains have been used to enhance SAM production (Chu et al, ; Chen, Wang, Cai, et al, ), such as the deletion of SPE2 encoding the S‐adenosylmethionine decarboxylase (Balasundaram, Dinman, Tabor, & Tabor, ) and GLC3 encoding a glycogen branching enzyme (Rowen, Meinke, & LaPorte, ), which are involved in SAM degradation and glycogen accumulation, respectively (Zhao, Hang, et al, ); the deletion of SAH1 encoding the S‐adenosyl‐ l ‐homocysteine hydrolase, which catalyzes the degradation of S‐adenosyl‐ l ‐homocysteine (Ano et al, ; Mizunuma, Miyamura, Hirata, Yokoyama, & Miyakawa, ) and the overexpression of S ‐adenosylmethionine synthetase (Chen, Wang, Wang, Dou, & Zhou, ; He, Deng, Zheng, & Gu, ; Zhao, Hang, et al, ; Zhao, Shi, et al, ) encoded by SAM2 , which catalyzes the transfer of the adenosyl group of ATP to the sulfur atom of methionine and was the rate‐limiting enzyme for SAM biosynthesis (Thomas, Rothstein, Rosenberg, & Surdin‐Kerjan, ). However, l ‐methionine was fed as the substrate for SAM production in most cases (Huang et al, ; Kamarthapu, Ragampeta, Rao, & Reddy, ; Zhang, Wang, Su, et al, ; Zhao, Hang, et al, ; Zhao, Shi, et al, ). Only one‐third of the price of l ‐methionine (Ren et al, ; Zhang, Gedicke, Kuznetsov, Staroverov, & Seidel‐Morgenstern, ), dl ‐methionine could be the cost‐saving substrate for industrial production of SAM.…”